读取中,请稍候

00-00 00:00:00
--.--
0.00 (0.000%)
昨收盘:0.000今开盘:0.000最高价:0.000最低价:0.000
成交额:0成交量:0买入价:0.000卖出价:0.000
市盈率:0.000收益率:0.00052周最高:0.00052周最低:0.000
百济神州:美股公告:临时报告8-K表格 下载公告
公告日期:2023-03-31

__________________________________________________________________________________________________

美国证券交易委员会华盛顿特区20549_____________________

8-K表格_____________________

根据1934年证券交易法第13或15(d)条规定提交的

临时报告

报告日期(所报告最早事件之日期):2023年3月27日

百济神州有限公司

BEIGENE, LTD.(注册人章程中列明的注册人准确名称)

开曼群岛
001-3768698-1209416

(注册地所在州或其他司法管辖区) (委员会档案编号) (国税局雇主识别号)

c/o Mourant Governance Services (Cayman) Limited

94 Solaris Avenue, Camana BayGrand Cayman KY1-1108

(主要办事处地址)(邮政编码)

Cayman Islands

+1 (345) 949 4123(注册人电话号码,包括区号)

不适用(如自上一份报告起有改动,则为公司曾用名或原地址)若8-K表格的呈递旨在同时满足下列任何条例项下的注册人报告义务,请勾选相应方格:

[ ]

根据证券法第425条发出书面通讯 (17 CFR 230.425)

[ ]

根据交易法第14a-12条的征集资料 (17 CFR 240.14a-12)

[ ]

根据交易法第14d-2(b)条发出生效日期前通讯 (17 CFR 240.14d-2(b))

[ ]

根据交易法第

条发出生效日期前通讯

(17 CFR 240.13e-4(c))

根据证券交易法第12(b)条注册的证券:

各类别名称交易代码)注册所在之各交易所名称
每股代表面值

0.0001

美元普通股之美国存托股

BGNE

纳斯达克全球精选市场(纳斯达克)

0.0001

美元之普通股

*06160

香港联合交易所有限公司(香港联交所)

*计入于证券交易委员会注册的美国存托股份(ADSs)。普通股并未于美国上市交易,但于香港联交所上市交易。

请标明注册人是否为1933年证券法第405条(17 CFR §230.405)或1934年证券交易法第12b-2条(17 CFR §240.12b-2)定义的新兴发展公司,如是,请勾选 [ ]

如注册人为上述新兴发展公司,请标明注册人是否选择不针对证券法第13(a)条规定的任何新的或修订的财务会计标准的合规使用延长过渡期,如是,请勾选[ ]

_________________________________________________________________________________________________

第8.01条 其他事件

经修订的独立董事薪酬政策

2023年3月27日,根据薪酬委员会的建议,百济神州有限公司(“本公司”)董事会批准修订本公司的独立董事薪酬政策(“经修订的独立董事薪酬政策”)。根据经修订的独立董事薪酬政策,独立董事将获得每年65,000美元的现金聘用金(较2022年批准的现有现金聘用金金额增加5,000美元)以及政策规定的担任董事会各个委员会的成员或主席的每年9,000美元至35,000美元不等的额外聘用金,相比2022年批准的政策规定的担任委员会主席的聘用金增加了2,000美元、3,000美元或10,000美元,担任委员会成员的聘用金增加了1,000美元、1,500美元或5,000美元。现金聘用金的金额变动自2023年4月1日起生效。股权授予的金额及构成较2022年批准的政策并无变化。经修订的独立董事薪酬政策的全文已作为此临时报告的附件10.1呈递并于此引用。上述条款摘要全文请参考该等附件。

第9.01条 财务报表及附件

附件(d)

附件编号说明
10.1百济神州有限公司独立董事薪酬政策(经修订)
104临时

报告

表格的封面,采用内联

XBRL

格式

附件列表

附件编号说明
10.1百济神州有限公司独立董事薪酬政策(经修订)
104临时

报告

表格的封面,采用内联

XBRL

格式

签字页根据1934年证券交易法要求,注册人已正式委托下列经正式授权的签署人代为签署本报告。

BEIGENE, LTD.

日期:2023年3月29日 签署人:

/s/ Chan Lee

姓名:

Chan Lee

职位:

高级副总裁、总法律顾问

附件10.1

BEIGENE, LTD.INDEPENDENT DIRECTOR COMPENSATION POLICY

百济神州有限公司独立董事薪酬政策

The purpose of this Independent Director Compensation Policy (this “Policy”) of BeiGene, Ltd. (the“Company”) is to provide a total compensation package that enables the Company to attract and retain, on along-term basis, high-caliber directors who meet the general independence requirements under NASDAQ Rule5605(a)(2) and Rule 3.13 of the Rules Governing the Listing of Securities on The Stock Exchange of HongKong Limited. In furtherance of this purpose, all members of the Board of Directors (the “Board”) of theCompany who are independent directors under NASDAQ Rule 5605(a)(2) shall be paid compensation forservices provided to the Company as set forth below:

百济神州有限公司(“本公司”)的独立董事薪酬政策(“本政策”)的目的是提供一套全面的薪酬方案,使本公司能够长期吸引和留住符合纳斯达克规则5605(a)(2)条及香港联合交易所有限公司证券上市规则第3.13条的一般独立性要求的高水平董事。为进一步实现这一目的,根据纳斯达克规则5605(a)(2)条认定为独立董事的所有本公司董事会(“董事会”)成员均应因向本公司提供下述服务而获得报酬:

Cash Retainers现金聘用金

Annual Retainer for Board Membership 董事成员年度聘用金
For general availability and participation in meetings and conference calls of the

Board. No additional compensation for attending individual Board meetings.出席董事会会议及电话会的总体情况。出席个别董事会会议无额外报酬。

$65,00065,000美元

Audit Committee Chairperson:

审计委员会主席:

35,000美元

$35,000
Audit Committee member:

审计委员会成员:

17,500美元

$17,500
Compensation Committee Chairperson:

薪酬委员会主席:

30,000美元Compensation Committee member:

薪酬委员会成员:

$15,000

15,000美元

$30,000Nominating and Corporate Governance Committee Chairperson:

提名及企业管治委员会主席:

Nominating and Corporate Governance Committee Chairperson:$18,000

18,000美元

提名及企业管治委员会成员:

Nominating and Corporate Governance Committee member:$9,000

9,000美元

Chairperson:

商业及医学事务咨询委员会主席:

Commercial and Medical Affairs Advisory Committee$20,000

20,000美元Commercial and Medical Affairs Advisory Committee member:

商业及医学事务咨询委员会成员:

$10,000

10,000美元

Scientific Advisory Committee Chairperson:

科学咨询委员会主席:

$20,00020,000美元Scientific Advisory Committee member:

科学咨询委员会成员:

$10,00010,000美元No additional compensation for attending individual committee meetings.出席个别委员会会议无额外报酬。

All cash retainers will be paid quarterly, in arrears, or upon the earlier resignation or removal of the independentdirector. Cash retainers owing to independent directors shall be annualized, meaning that independent directorswho join the Board during the calendar year, such amounts shall be pro-rated based on the number of calendardays served by such director.所有现金聘用金将按季度支付,或在独立董事提前辞任或被免职时支付。应付给独立董事的现金聘用金应按年计算,即在日历年度内加入董事会的独立董事,其数额应根据该董事任职的日历天数按比例计算。

Equity Retainers股权聘用金Upon initial election or appointment to the Board: An initial equity grant (the “Initial Grant”) on the date ofsuch election or appointment (the “grant date” for the Initial Grant) with an initial value of $400,000 on thegrant date, pro-rated based on the number of calendar days to be served from the grant date until the firstanniversary of the most recent Annual Meeting.首次当选或获委任加入董事会:首次当选或获委任加入董事会之日(首次授予的“授予日期”)以购股权的形式获授价值400,000美元的首次股权授予("首次授予"),首次授予的价值按上届股东周年大会首个周年的任职年度之比例计算。

Annual equity grants: On the date of the Company’s Annual Meeting of Shareholders (the “Annual Meeting”),each continuing independent member of the Board who is eligible to receive awards under this Plan will receivean annual equity grant (the “Annual Grant”) with an initial value of $400,000 on the date of grant.年度股权授予:在本公司股东周年大会(以下简称“周年大会”)举行之日,每一位有资格根据本计划获得股权授予的继续具有独立性的董事将在授予日获得初始价值为40万美元的年度股权授予(以下简称“年度授予”)。

Terms and Conditions of Initial Grant and Annual Grant: Each of the Initial Grant and the Annual Grant(together, the “Equity Awards”) shall consist of 50% share options (“Options”) and 50% restricted share units(“RSUs”); provided, however, that to the extent that a grant of RSUs is subject to shareholder approval pursuantto applicable listing rules, (i) the Initial Grant shall consist of 100% Options and (ii) the Annual Grant shallinclude RSUs only upon shareholder approval and, in the absence of such shareholder approval, the AnnualGrant shall consist of 100% Options. The number of Options awarded will be the applicable grant value dividedby the per share option value on the date of grant determined in accordance with the Company’s standardoption valuation practices, and the number of RSUs awarded will be the applicable grant value divided by thefair market value per share of the Company’s shares on the date of grant. The Options will have an exerciseprice equal to the higher of (i) the fair market value per share of the Company’s shares on the date of grant,and (ii) the average fair market value per share of the Company’s shares for the five trading days immediatelypreceding the date of grant. The Equity Awards shall be governed by, and subject to the terms and conditionsof, the Company’s 2016 Share Option and Incentive Plan (as may be amended from time to time) and standardform of grant agreements in effect on the date of grant. In addition, the Equity Awards shall vest in full (i.e.,in a single installment) upon the earlier to occur of the first anniversary of the date of grant or the date of thenext Annual Meeting; provided, however, that all vesting shall cease if the director resigns from the Board orotherwise ceases to serve as a director other than as set forth below or the Board determines that the

circumstances warrant continuation of vesting. In addition, all Options shall be exercisable for three yearsfollowing cessation of service, and all Equity Awards shall accelerate in full upon (i) death, (ii) disability, (iii)termination of service in connection with a change of control of the Company, or (iv) upon a change of controlof the Company if the director’s service continues and the awards are not assumed by the acquiror at the timeof the change of control. Subject to specific terms and conditions designed for compliance with applicable taxand other regulations, directors generally may elect to defer settlement of their RSUs until six months followingthe date that the director ceases to serve as a director.首次授予及年度授予之条款及条件:每项首次授予及年度授予(合称“股权授予”)由50%购股权及50%受限制股份单位组成,然而,若授出受限制股份单位须根据适用的上市规则取得股东批准,则(i)首次授予由100%购股权组成及(ii)年度授予仅于取得股东批准后方可包括受限制股份单位,在未取得该等股东批准的情况下,年度授予由100%购股权组成。授予的购股权数量将为适用的授予价值除以授予日的每股购股权价值,该购股权价值根据公司的标准期权估值惯例确定。授予的受限制股份单位数量为适用的授予价值除以授予日本公司每股股票的公平市场价值。购股权的行使价为(i)本公司普通股于授出日期的公平市场价值及(ii)本公司普通股于紧接授出日前五个交易日的平均公平市场价值之间的较高者。股权授予应受本公司2016年期权及激励计划(经不时修订)以及在授予日有效的标准形式的授予协议的条款和条件约束。此外,股权授予将于授出日期首个周年日或下届股东周年大会日期(以较早者为准)全数归属(即一次性归属),但是,如果董事从董事会辞任,或在以下规定以外的情况下不再担任董事,则所有归属应停止;或者除非董事会认定相关情况有必要继续归属。此外,所有购股权应在终止担任董事后的三年内行使,所有股权授予应在(i)身故、(ii)伤残、(iii)因公司控制权变更而终止任职、或(iv)在公司控制权发生变化时,如果董事继续任职,且在控制权发生变化时,股权授予并非由收购方继受。受限于为符合适用税务及其他法规而设的特定条款及条件,董事通常可选择将其受限制股份单位的结算推迟至董事任职结束之日后六个月。

Limitations on Independent Director Compensation独立董事薪酬限制

Cash and equity compensation payable to independent directors under this Policy shall be subject to any limits,terms and conditions set forth in any Company policy or equity incentive plan or as otherwise adopted by theBoard from time to time.根据本政策向独立董事支付的现金和股权薪酬应受公司政策或股权激励计划中规定的任何限制、条款和条件或董事会不时批准的其他限制、条款和条件的约束。

Expenses费用

The Company shall reimburse all reasonable out-of-pocket expenses incurred by independent directors inattending Board and committee meetings.本公司应报销独立董事出席董事会及委员会会议产生的所有合理实际费用。

ADOPTED: November 16, 2016批准日期:2016年11月16日EFFECTIVE: November 16, 2016生效日期:2016年11月16日AMENDED: June 6, 2018, June 5, 2019, April 13, 2020, April 5, 2021* and February 17, 2022*修订日期:2018年6月6日、2019年6月5日、2020年4月13日、2021年4月5日*、2022年2月17日*及2023年3月27日*

* Changes regarding the cash retainers will become effective on April 1.关于现金聘用金的变更将于4月1日生效。


  附件:公告原文
返回页顶